Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-039239

Director sold 1,000 shares at $13.15 ($13,150)

  • Director acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gallagher Carol Giltner Director 2017-06-08 Grant or award +5,000 108,374 D
Gallagher Carol Giltner Director 2017-06-09 Sale −1,000 $13.15 $13,150 107,374 D
Derivatives
Gallagher Carol Giltner Director 2017-06-08 Grant or award · Non-Qualified Stock Option (Right to Buy) +21,500 21,500 D
Open-market sales · 1,000 sh · avg $13.15 · $13,150
Loading xslF345X03/doc4.xml…